Alkem subsidiary Enzene launches adalimumab biosimilar in India

Enzene or its parent Alkem which is commercialising the drug didn't announce the price, but said it would be competitively priced.

from Latest Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/BUhxr9O
https://ift.tt/36ZN5E4

Post a Comment

Previous Post Next Post